EN PL
REVIEW PAPER
The human body as an energetic hybrid? New perspectives for chronic disease treatment?
 
More details
Hide details
 
Submission date: 2016-11-29
 
 
Acceptance date: 2017-04-19
 
 
Online publication date: 2017-04-28
 
 
Publication date: 2017-04-28
 
 
Reumatologia 2017;55(2):94-99
 
KEYWORDS
TOPICS
ABSTRACT
Inflammatory response is accompanied by changes in cellular energy metabolism. Proinflammatory mediators like plasma C-reactive protein, IL-6, plasminogen activator inhibitor-1, TNF- or monocyte chemoattractant protein-1 released in the site of inflammation activates immune cells and increase energy consumption. Increased demand for energy creates local hypoxia and lead in consequence to mitochondrial dysfunction. Metabolism of cells is switched to anaerobic glycolysis. Mitochondria continuously generate free radicals that what result in imbalance that causes oxidative stress, which results in oxidative damage. Chronic energy imbalance promotes oxidative stress, aging, and neurodegeneration and is associated with numerous disorders like Alzheimer’s disease, multiple sclerosis, Parkinson’s disease or Huntington’s disease. It is also believed that oxidative stress and the formation of free radicals play an important role in the pathogenesis of rheumatoid diseases including especially rheumatoid arthritis. Pharmacological control of energy metabolism disturbances may be valuable therapeutic strategy of treatment of this disorders. In recent review we sum up knowledge related to energy disturbances and discuss phenomena such as zombies or hibernation which may indicate the potential targets for regulation of energy metabolism.
 
REFERENCES (38)
1.
Straub RH. Evolutionary medicine and chronic inflammatory state-known and new concepts in pathophysiology. J Mol Med (Berl) 2012; 90: 523-534.
 
2.
Romson JL. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983; 67: 1016-1023.
 
3.
Aller MA, Arias JL, Arias J. Post-traumatic inflammatory response: perhaps a succession of phases with nutritional purpose. Med Hypotheses 2004; 63: 42-46.
 
4.
Delmastro-Greenwood MM, Piganelli JD. Changing the energy of an immune response. Am J Clin Exp Immunol 2013; 2: 30-54.
 
5.
Gajewski M, Laskowska-Bożek H, Moutiris JA, et al. Enhanced responsiveness of rat cardiac myocytes to muscarinic cholinergic stimulation during chemically-induced hypoxia. Acta Neurobiol Exp 1993; 53: 79-91.
 
6.
Gajewski M, Laskowska-Bożek, Maśliński S, et al. Increase in the expression of muscarinic cholinergic receptors in isolated, neonatal rat cardiac myocytes treated with potassium cyanide. Acta Biochim Pol 1991; 38: 61-65.
 
7.
Bany U, Gajewski M, Księżopolska-Pietrzak K, et al. Expression of mRNA encoding muscarinic receptor subtypes in neutrophils of patients with rheumatoid arthritis. Ann NY Acad Sci 1999; 876: 301-304.
 
8.
Gajewski M, Gujski M, Księżopolska-Pietrzak K, et al. The influence of adrenergic and cholinergic agents on the respiratory burst of human neutrophils from peripheral blood and synovial fluid. J Physiol Pharmacol 1997; 48: Suppl. 2: 72-79.
 
9.
Gajewski M, Moutiris JA, Maslinski S, et al. The neuromodulation aspects of ischemic myocardium: the importance of cholinergic system. J Physiol Pharmacol 1995; 46: 107-125.
 
10.
Hansen JC, Gilman AP, Odland JØ. Is thermogenesis a significant causal factor in preventing the “globesity” epidemic? Med Hypotheses 2010; 75: 250-256.
 
11.
Aller MA, Arias N, Fuentes-Julian S, et al. Coupling inflammation with evo-devo. Med Hypothesis 2012; 78: 721-731.
 
12.
Straub RH, Cutolo M, Buttgereit F, et al. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med 2010; 267: 543-560.
 
13.
Straub RH, Besedovsky HO. Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J 2003; 17: 2176-2183.
 
14.
Brand KA, Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against oxygen species. FASEB J 1997; 11: 388-395.
 
15.
Gajewski M, Rzodkiewicz P, Wojtecka-Łukasik E. The role of physiological elements in the future therapies of rheumatoid arthritis. II. The relevance of energy redistribution in the process of chronic inflammation. Reumatologia 2015; 53: 40-45.
 
16.
Leszek J, Barreto GE, Gąsiorowski KK, et al. Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System. CNS Neurol Disord Drug Targets 2016; 15: 329-336.
 
17.
Langston JW, Ballard P, Tetrud JW, et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219: 979-980.
 
18.
Yun JW, Ahn JB, Kang BC. Modeling Parkinson’s disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal care. Lab Anim Res 2015; 31: 155-165.
 
19.
Yan MH, Wang X, Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radical Biol Med 2013; 62: 90-101.
 
20.
Albuquerque UP, Melo JG, Medeiros MF, et al. Natural products from ethnodirected studies: revisiting the ethnobiology of the zombie poison. Evidence-Based Complementary and Alternative Medicine vol. 2012, articles ID 202508, 19 pages doi:10.1155/2012/202508.
 
21.
Littlewood R, Douyon C. Clinical findings in three cases of zombification. Lancet 1997; 350: 1094-1096.
 
22.
Kheifets J, Rozhavsky B, Solomonovich ZG, et al. Severe tetrodotoxin poisoning after consumption Lagocephalus sceleratus (Pufferfish, Fugu) fished in Mediterranean Sea, treated with cholinesterase inhibitor. Case Rep Crit Care 2012; 2012: 782507. doi: 10.1155/2012/782507.
 
23.
Yin HL, Lin HS, Huang CC, et al. Tetrodotoxication with Nassauris Glans: A possibility of tetrodotoxin spreading in marine products near Pratas Islands. Am J Trop Med Hyg 2005; 73: 985-990.
 
24.
Johar K, Priva A, Wong-Riley MT. Regulation of Na(+)/K(+)-ATPase by neuron-specific transcription factor Sp4: implication in the tight coupling of energy production, neuronal activity and energy consumption in neurons. Eur J Neurosci 2014; 39: 566-578.
 
25.
Fernandes VS, Xin W, Petkov GV. Novel mechanism of hydrogen sulfide-induced guinea pig urinary bladder smooth muscle contraction: role of BK channels and cholinergic neurotransmission. Am J Cell Physiol 2015; 309: C107-C116.
 
26.
Gong QH, Shi XR, Hong ZY, et al. A new hope for neurodegeneration: possible role of hydrogen sulfide. J Alzheimers Dis 2011; 24 (Suppl 2): 173-182.
 
27.
Szabo C. Gaseotransmitters: New Frontiers for Translational Science. Sci Transl Med 2010; 2: 59ps54; doi:10.1126/scitranslmed.3000721.
 
28.
Gajewski M, Maslinski S, Rzodkiewicz P, et al. Gas-Therapy in Rheumatoid Arthritis Treatment: When West Meets East – Actual Medical Concepts with Ancient World Ideas. Innovative Rheumatology InTech (Charpter 9) 2013; 189-213. Available at: https://www.intechopen.com/boo....
 
29.
Cloud P. Atmospheric cycles of carbon and sulfur and their effect on atmospheric oxygen over Phanerozoic time. Paleogeography, Paleoclimatology, Paleoecology 1988; 75: 97-122.
 
30.
Nichols P, Marshall DC, Cooper CE, et al. Sulfide inhibition of and metabolism by cytochrome c oxidase. Biochem Soc Transaction 2013; 41: 1312-1316.
 
31.
Modis K, Bos EM, Calzia E, et al. Regulation of mitochondrial bioenergetics function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects. Br J Pharmacol 2014; 171: 2123-2146.
 
32.
Blackstone E, Morrison M, Roth MB. H2S induces a suspended animation-like state in mice. Science 2005; 308: 518.
 
33.
Revsbech IG, Shen X, Chakravarti R, et al. Hydrogen sulfide and nitric oxide metabolites in the blood of free-8ranging brown bears and their potential roles in hibernation. Free Rad Biol Med 2014; 73: 349-357.
 
34.
Chung DJ, Szyszka B, Brown JCL, et al. Changes in the mitochondrial phosphoproteome during mammalian hibernation. Physiol Genomics 2013; 45: 389-399.
 
35.
Gallagher K, Staples JF. Metabolism of brain cortex and cardiac muscle mitochondria in hibernating 13-lined ground squirrels Ictidomys tridecemlineatus. Physiol Biochem Zool 2013; 86: 1-8.
 
36.
Hochachka PW, Somero GN. Biochemical Adaptation: Mechanism and Process in Physiological Evolution. Oxford Univ Press, Oxford 2002.
 
37.
Ramirez JM, Folkow LP, Blix AS. Hypoxia tolerance in mammals and birds: from the wilderness to the clinic. Ann Rev Physiol 2007; 69: 113-143.
 
38.
Bossy-Wetzel E, Lipton SA. Nitric oxide signaling regulates mitochondrial number and function. Cell Death Differ 2003; 10: 757-760.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top